SCHEMBL1703115

SCHEMBL1703115

CC(C)(C)n1c(=O)cnc2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ KDM4E B2RXH2 14/20 0.50
▸ ALDH1A1 P00352 12/20 0.50
▸ HPGD P15428 3/20 0.47
▸ HSD17B10 Q99714 5/20 0.47
▸ TDP1 Q9NUW8 3/20 0.44
▸ LMNA P02545 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ MAPT P10636 2/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ GMNN O75496 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ APEX1 P27695 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10722269 0.84 TDP1 (0.52) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL21202580 0.77 GRIN2B (0.37) KMT2AMEN1KDM4EALDH1A1TDP1
SCHEMBL29580418 0.76 KDM4E (0.51) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL6390410 0.76 KDM4E (0.51) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL20687542 0.74 ALDH1A1 (0.43) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL2359406 0.72 KDM4E (0.51) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL29834958 0.72 KDM4E (0.51) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL28264383 0.72 KDM4E (0.51) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL8861255 0.72 ALDH1A1 (0.51) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL7898823 0.72 KDM4E (0.56) KMT2AMEN1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440528-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-04-18 — — EP disclosed
WO-2010142656-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-12-16 — — WO disclosed
Send feedback